Actionable news
0
All posts from Actionable news
Actionable news in RARE: ULTRAGENYX PHARMACEUTICAL Inc,

Cowen Analyst Reiterates Outperform on Ultragenyx Pharmaceutical Inc (RARE) Following Positive Clinical Update

At the 14th International Symposium on MPS and Related Diseases, Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) presented positive pivotal Phase 3 trial of recombinant human beta-glucuronidase (rhGUS) in replacement therapy in development for Mucopolysaccharidosis 7 (MPS 7).

In reaction, Cowen analyst Eric Schmidt reiterated an Outperform rating on the stock, without providing a price target.

Schmidt commented, “Despite MPS7 being a progressive disease and a trial size of just 12 patients, rhGUS nearly provided a statistically significant improvement at 24-weeks relative...


More